Immunome, Inc. , a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced the U.S. Food and Drug Administration (FDA or the Agency) ...
Medicaid payment error rates under H.R. 1 could rise due to work requirements and other changes that make eligibility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results